SCHEMBL13484378

SCHEMBL13484378

COc1ccc2cc(/C=C(\C)N(O)O)ccc2c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NQO2 P16083 3/20 0.45
CYP1A2 P05177 2/20 0.44
CYP2A6 P11509 1/20 0.44
MAOB P27338 1/20 0.43
CYP1A1 P04798 2/20 0.42
CYP1B1 Q16678 2/20 0.42
NFE2L2 Q16236 2/20 0.42
KDM4E B2RXH2 2/20 0.42
LMNA P02545 1/20 0.42
ALOX12 P18054 1/20 0.42
PTGS1 P23219 1/20 0.42
PTGS2 P35354 1/20 0.42
TUBB1 Q9H4B7 2/20 0.42
APP P05067 2/20 0.42
MTNR1A P48039 1/20 0.42
MTNR1B P49286 1/20 0.42
TUBB4A P04350 1/20 0.41
TUBB P07437 1/20 0.41
TUBA3C P0DPH7 1/20 0.41
TUBA1B P68363 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13484115 0.82 CYP1A2 (0.50) NQO2CYP1A2CYP2A6MAOBCYP1A1
SCHEMBL7345665 0.77 RELA (0.49) NQO2CYP1A2CYP2A6MAOBCYP1A1
SCHEMBL21470094 0.77 MAOB (0.49) NQO2CYP1A2CYP2A6MAOBKDM4E
SCHEMBL14325968 0.77 MAOB (0.46) NQO2CYP1A2CYP2A6MAOBCYP1A1
SCHEMBL7158461 0.73 MAPT (0.72) NQO2CYP1A2CYP2A6KDM4ELMNA
SCHEMBL29818623 0.73 EGFR (0.56) CYP1A2MAOBNFE2L2KDM4ELMNA
SCHEMBL14303313 0.73 EGFR (0.56) CYP1A2MAOBNFE2L2KDM4ELMNA
SCHEMBL28673144 0.73 EGFR (0.56) CYP1A2MAOBNFE2L2KDM4ELMNA
SCHEMBL9443956 0.72 CYP1A2 (0.56) NQO2CYP1A2CYP2A6MAOBCYP1A1
SCHEMBL12732162 0.72 MAPT (0.50) MAOBKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8337941-B2 Fluorescent substrates for monoamine transporters as optical false neurotransmitters THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) 2012-12-25 US disclosed
US-20100035279-A1 Fluorescent Substrates for Monoamine Transporters as Optical False Neurotransmitters NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2010-02-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100035279-A1 Fluorescent Substrates for Monoamine Transporters as Optical False Neurotransmitters SLC18A2, SLC6A2, SLC18A3 NQO2 248/4885CYP1A2 1053/4885CYP2A6 1899/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.